Neuren Pharmaceuticals with Proactive at ASX Small and Mid-Cap Conference, page-73

All this is doing my head in.

We are suddenly at 7 bucks - hard to believe after the long struggle to get past 4 - and the lamentable situation of being almost down to just over 1 post the ACADS deal.

All I am focussed on now is the next 6 months leading up to FDA decision. Appears to be a lay down misere, but I've seen them beaten (more than once).

Not even interested in attempts to value the company until that time. If in advance, any decent ROW deal will likely be dependent on that approval.

The numbers being bandied about here are possible but (IMO) not even worth debate atm. So much water must pass under the bridge for them to come to fruition.

Even if all goes well over the coming 9 months or so, a takeover will likely spoil the mega SP dollars scenario.

The major holders may not hold those dreams. JP comes from a bean counting background and has referenced a possible sell out a number of times.

Nah, baby steps for me until Trof approval.